| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 2.2% stake in EXIT FILING EMERGENT BIOSOLUTIONS INC |
| 10/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.1% stake in Emergent BioSolutions Inc. |
| 10/05/2023 |
4
| Fowler Neal Franklin (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 118,670 shares
@ $0 |
|
| 10/05/2023 |
4
| DeGolyer Donald W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 118,670 shares
@ $0 |
|
| 10/05/2023 |
3
| Fowler Neal Franklin (Director) has filed a Form 3 on Emergent BioSolutions Inc. |
| 10/05/2023 |
3
| DeGolyer Donald W (Director) has filed a Form 3 on Emergent BioSolutions Inc. |
| 10/05/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/15/2023 |
3
| Hartzel William (SVP, Bioservices) has filed a Form 3 on Emergent BioSolutions Inc. |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/08/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/31/2023 |
8-K
| Investor presentation |
| 05/30/2023 |
4
| Zoon Kathryn C (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| White Marvin L (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Hauer Jerome M (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Richard Ronald (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Katkin Keith (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Harsanyi Zsolt (Chairman) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Dayal Sujata Tyagi (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/18/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/15/2023 |
8-K
| Asset disposition |
| 05/09/2023 |
8-K
| Quarterly results |
| 04/24/2023 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 04/17/2023 |
8-K
| Quarterly results |
|